Research programme: GLP-1R positive allosteric modulators - ReceptosAlternative Names: RPC-8844
Latest Information Update: 16 Sep 2016
At a glance
- Originator Receptos
- Class Small molecules
- Mechanism of Action Glucagon-like peptide 1 receptor modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Type 2 diabetes mellitus